期刊首页 优先出版 当期阅读 过刊浏览 作者中心 关于期刊 English

2011年 第5卷 第3期

摘要

关键词

相关研究

回顶部

《医学前沿（英文）》 >> 2011年 第5卷 第3期 doi: 10.1007/s11684-011-0148-4

Towards the optimization of management of hepatocellular carcinoma

1. Division of Surgery, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK; 2. Tbilisi 1st Hospital University Clinic, High Technology Medical Center, Tbilisi 0144, Georgia

发布日期： 2011-09-05
HTML22 PDF 1 收藏 0

下一篇 上一篇

摘要

Hepatocellular carcinoma (HCC) is the fifth most common neoplasm in the world, closely correlated with viral hepatitis and liver cirrhosis. The vast majority of HCC patients present at a late stage and are unsuitable for surgery due to limited liver functional reserve. Tumors can involve major vessels or hilar structures, necessitating major liver resection and/or rendering liver resection unfeasible. A series of new technologies have been developed to optimise HCC management. Stem cell therapy improves impaired liver functional reserve prior to liver resection. Intravascular radiofrequency ablation recanalises the portal vein invaded by tumour thrombus and endobiliary radiofrequency ablation restores and extends biliary patency of the bile duct invaded by malignancy. Laparoscopic radiofrequency assisted liver resection minimizes blood loss and avoids liver warm ischemia, while increasing parenchymal sparing. These benefits combined maximize the safety of liver resection.

相关研究